nothing is perfect..
I understand your concern, and thank you for the info especially relevant for bone mets to considere. I had dose dense chemo and became neutropenic, spent four days at hospital on drip when I had temperature, so G-CSF/neul for me was a welcome trade off for the rest of my treatment, so I would not be scared around people and my "lick everything that looks dirty" dog!! Luckily I did not get bone pain from it, and no apparent side effect except a huge WBC count, once up to 35 on neul. In a twisted way I told my self that these extra WBC may come useful at killing my herceptin marked cancer cell (antibodies), not sure it works that way but hey that was a reassuring thought..
Unfortunatly for what we have trade off and bashing at one thing to save another is the name of the game.
Love
Karina
__________________
35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies
Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009: to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..
superior vena cava blocked: stent but face remains puffy
April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
'Under no circumstances should you lose hope..' Dalai Lama
|